Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Koppel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|September 1, 1976
Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporinsD F Mahoney, G A Koppel, J R Turner
Journal of Pharmacological Methods|August 1, 1981
Schultz-Dale reaction in mouse tracheaG A Koppel, K D Haisch, S M Spaethe, et al.
The Journal of Experimental Medicine|March 1, 1983
Synthetic Fc peptide-mediated regulation of the immune response. I. Characterization of the immunomodulating properties of a synthetic 23-amino acid peptide derived from the sequence of the CH3 domain of human IgG1E L Morgan, J E Shields, C S Campbell, et al.
Cancer Research|July 15, 1992
Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27M Schrappe, T F Bumol, L D Apelgren, et al.
Life Sciences|January 1, 1996
A novel class of 5-HT2A receptor antagonists: aryl aminoguanidinesH U Bryant, D L Nelson, D Button, et al.
Bioconjugate Chemistry|March 1, 1993
Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructsL D Apelgren, D L Bailey, S L Briggs, et al.
FEBS Letters|September 16, 1996
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratC C Felder, A Nielsen, E M Briley, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulationC C Felder, K E Joyce, E M Briley, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|September 1, 1976
Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporinsD F Mahoney, G A Koppel, J R Turner
Journal of Pharmacological Methods|August 1, 1981
Schultz-Dale reaction in mouse tracheaG A Koppel, K D Haisch, S M Spaethe, et al.
The Journal of Experimental Medicine|March 1, 1983
Synthetic Fc peptide-mediated regulation of the immune response. I. Characterization of the immunomodulating properties of a synthetic 23-amino acid peptide derived from the sequence of the CH3 domain of human IgG1E L Morgan, J E Shields, C S Campbell, et al.
Cancer Research|July 15, 1992
Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27M Schrappe, T F Bumol, L D Apelgren, et al.
Life Sciences|January 1, 1996
A novel class of 5-HT2A receptor antagonists: aryl aminoguanidinesH U Bryant, D L Nelson, D Button, et al.
Bioconjugate Chemistry|March 1, 1993
Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructsL D Apelgren, D L Bailey, S L Briggs, et al.
FEBS Letters|September 16, 1996
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratC C Felder, A Nielsen, E M Briley, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulationC C Felder, K E Joyce, E M Briley, et al.
Pageof 1